Response to aminoglutethimide and cortisone acetate in advanced prostatic cancer

Forty patients with metastatic adenocarcinoma of the prostate were evaluated for response to treatment with aminoglutethimide plus cortisone acetate. All had relapsed from or failed to respond to primary endocrine treatment with orchidectomy or stilboestrol. Nineteen patients (48%) showed subjective...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of cancer 1984-12, Vol.50 (6), p.757-763
Hauptverfasser:	Ponder, B A, Shearer, R J, Pocock, R D, Miller, J, Easton, D, Chilvers, C E, Dowsett, M, Jeffcoate, S L
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma - drug therapy Aged Aminoglutethimide - adverse effects Aminoglutethimide - therapeutic use Androstenedione - blood Antineoplastic agents Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biological and medical sciences Biomedical and Life Sciences Biomedicine Cancer Research Chemotherapy Cortisone - analogs & derivatives Cortisone - therapeutic use Dehydroepiandrosterone - blood Dihydrotestosterone - blood Drug Resistance Epidemiology Humans Male Medical sciences Middle Aged Molecular Medicine Oncology original-article Pharmacology. Drug treatments Prostatic Neoplasms - blood Prostatic Neoplasms - drug therapy Sleep Stages Testosterone - blood
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!